Harrow Inc (HROW) financials

NASDAQ · Health Care

$28.24 -5.84% Close Oct 30, 2026 Live

Harrow revenue and earnings by year

Harrow's revenue was $272 million in the fiscal year to December 31, 2025, up 36.4% from the year before. Net income was -$5.14 million, -1.9% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 33.7% a year on average.

RevenueNet income
$0$100M$200M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue27220013089724951412720
Revenue growth36.4%53.3%47.0%22.2%48.3%-4.5%23.7%54.5%34.3%—
Gross profit2041509163543434251310
Gross margin75.1%75.3%69.6%71.3%74.9%70.4%67.3%60.1%49.6%50.7%
Operating income3190220-5-5-12-16
Operating margin11.2%4.4%0.3%2.2%2.2%0.8%-9.4%-12.6%-45.4%-79.6%
Net income-5-17-24-14-18-3015-12-19
Net margin-1.9%-8.8%-18.7%-15.9%-24.8%-6.9%0.3%35.3%-44.8%-95.7%
Diluted EPS-$0.14-$0.49-$0.75-$0.51-$0.68-$0.13$0.01$0.59-$0.61-$1.52
Free cash flow43-242-13-2-1-1-10-18

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open HROW in Markets.

How Harrow makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Branded$56.1M79.4%
Compounding$14.6M20.6%

See also: HROW returns

No forecast, no recommendation. This page describes Harrow Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.